Cullinan Associates Inc Biogen Inc. Transaction History

Cullinan Associates Inc

$1.81 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 07, 2022	SELL	$223.92 - $287.77 $594,283 - $763,741	-2,654 Reduced 70.7%	1,100 $264,000
Q3 2021 Oct 08, 2021	BUY	$282.99 - $369.05 $33,958 - $44,286	120 Added 3.3%	3,754 $1.06 Million
Q2 2021 Jul 07, 2021	SELL	$259.0 - $414.71 $3.11 Million - $4.98 Million	-12,000 Reduced 76.76%	3,634 $1.26 Million
Q1 2021 Apr 20, 2021	BUY	$242.95 - $284.63 $1.8 Million - $2.11 Million	7,420 Added 90.33%	15,634 $4.37 Million
Q4 2020 Jan 14, 2021	SELL	$236.26 - $355.63 $3.09 Million - $4.65 Million	-13,074 Reduced 61.41%	8,214 $2.01 Million
Q3 2020 Oct 09, 2020	SELL	$264.77 - $305.71 $367,765 - $424,631	-1,389 Reduced 6.13%	21,288 $6.04 Million
Q2 2020 Jul 07, 2020	BUY	$258.66 - $342.55 $1.7 Million - $2.25 Million	6,578 Added 40.86%	22,677 $6.07 Million
Q1 2020 Apr 01, 2020	BUY	$268.85 - $341.04 $5,377 - $6,820	20 Added 0.12%	16,099 $5.09 Million
Q4 2019 Jan 15, 2020	SELL	$220.06 - $304.07 $61,836 - $85,443	-281 Reduced 1.72%	16,079 $4.77 Million
Q3 2019 Oct 01, 2019	BUY	$217.44 - $243.88 $282,019 - $316,312	1,297 Added 8.61%	16,360 $3.81 Million
Q2 2019 Jul 16, 2019	SELL	$219.29 - $241.72 $1.37 Million - $1.51 Million	-6,257 Reduced 29.35%	15,063 $3.52 Million
Q1 2019 Apr 30, 2019	BUY	$216.71 - $338.96 $795,975 - $1.25 Million	3,673 Added 20.81%	21,320 $5.04 Million
Q4 2018 Jan 11, 2019	BUY	$278.5 - $352.75 $1.62 Million - $2.05 Million	5,820 Added 49.21%	17,647 $5.31 Million
Q3 2018 Oct 19, 2018	BUY	$293.51 - $383.83 $434,101 - $567,684	1,479 Added 14.29%	11,827 $4.18 Million
Q2 2018 Jul 09, 2018	BUY	$257.52 - $306.91 $2.66 Million - $3.18 Million	10,348 New	10,348 $3 Million
Q1 2018 Apr 27, 2018	SELL	$260.13 - $367.91 $169,084 - $239,141	-650 Closed	0 $0
Q3 2017 Oct 16, 2017	BUY	$281.15 - $329.69 $182,747 - $214,298	650	650 $204,000

Others Institutions Holding BIIB

# of Institutions

1,032

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cullinan Associates Inc with notifications on news.

Account